News & Updates

Oral antibiotics not inferior to IV-only therapy in blood, bone infections
Oral antibiotics not inferior to IV-only therapy in blood, bone infections
21 Mar 2022

Use of oral antibiotics in the treatment of osteomyelitis, bacteraemia, and infective endocarditis results in shorter hospital stay, has a better safety profile, and appears to be similarly effective when compared to intravenous (IV)-only therapy, a recent study has shown.

Oral antibiotics not inferior to IV-only therapy in blood, bone infections
21 Mar 2022
Omicron more stable than ancestral strain on surfaces, resistant to neutralizing mAbs
Omicron more stable than ancestral strain on surfaces, resistant to neutralizing mAbs
21 Mar 2022 byChristina Lau

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more stable than the ancestral strain on various smooth and porous surfaces and demonstrates marked resistance to neutralizing monoclonal antibodies (mAbs), researchers from the University of Hong Kong (HKU) have reported.

Omicron more stable than ancestral strain on surfaces, resistant to neutralizing mAbs
21 Mar 2022
Lower resilience tied to poorer medication adherence in glaucoma patients
Lower resilience tied to poorer medication adherence in glaucoma patients
18 Mar 2022 byStephen Padilla

The COVID-19 pandemic has worsened the adherence to ocular hypotensive medication among patients with primary open-angle glaucoma (POAG), according to a study. Such reduction is potentially driven by lower psychometric measures of resilience and more confrontational coping strategies.

Lower resilience tied to poorer medication adherence in glaucoma patients
18 Mar 2022
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
17 Mar 2022 byRoshini Claire Anthony

Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.

Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
17 Mar 2022